[HTML] mdpi.com

[HTML][HTML] A role for TGFβ signaling in preclinical osteolytic estrogen receptor-positive breast cancer bone metastases progression

JN Cheng, JB Frye, SA Whitman, AG Kunihiro… - International Journal of …, 2021 - mdpi.com
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …
被引用次数：9 相关文章

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression

JN Cheng, JB Frye, SA Whitman… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.

JN Cheng, JB Frye, SA Whitman… - … Journal of Molecular …, 2021 - europepmc.org
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …
[PDF] semanticscholar.org

[PDF][PDF] A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression

JN Cheng, JB Frye, SA Whitman… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …

A role for tgfβ signaling in preclinical osteolytic estrogen receptor-positive breast cancer bone metastases progression

JN Cheng, JB Frye, SA Whitman, AG Kunihiro… - 2021 - repository.arizona.edu
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …
[HTML] nih.gov

[HTML][HTML] A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression

JN Cheng, JB Frye, SA Whitman… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.

JN Cheng, JB Frye, SA Whitman… - International …, 2021 - search.ebscohost.com
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression

JN Cheng, JB Frye, SA Whitman, AG Kunihiro… - 2021 - agris.fao.org
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression

JN Cheng, JB Frye, SA Whitman… - International …, 2021 - search.proquest.com
While tumoral Smad-mediated transforming growth factor β (TGFβ) signaling drives
osteolytic estrogen receptor α-negative (ER-) breast cancer bone metastases (BMETs) in …